• Letrozole 2.5 mg

Packing : 20 x 5

Femihost Tablets contain Letrozole 2.5 mg, an aromatase inhibitor used primarily in the management of hormone-sensitive breast cancer in postmenopausal women. It works by reducing estrogen production in the body, helping slow or prevent the growth of estrogen-dependent cancer cells. Letrozole may also be prescribed by fertility specialists for ovulation induction in women with certain types of infertility, particularly in patients with ovulatory dysfunction. The use of Femihost should be based on the specific clinical indication and medical supervision. For safe and effective treatment, Femihost Tablets should be taken strictly as advised by your doctor or healthcare professional.